Neoplasia/BPH

	Clinical Significance of the C-Reactive Protein-Triglyceride-Glucose Index in Cardiovascular Disease, Stroke, Cardiovascular-Kidney-Metabolic Syndrome, Cancer, Diabetes, and Osteoporosis: A Narrative Review. Int J Gen Med Yang S, Yao X, Chai J, Lu H, Tang W, Wu Z, He W, Xie Y. PMID: 42273529 [PubMed]
	Causal Association Between Gut Microbiota, Plasma Metabolites, and Prostate Cancer: Two-Step Mendelian Randomization Study. Dose Response Li J, Hou J, Liu H, Fan S, Wang Y, Liang P, Qin J, Gu P, Liu X, Wen X. PMID: 42273390 [PubMed]
	Evaluation of MRI-based risk models versus PI-RADS version 2.1 and arterial spin labeling perfusion imaging strategy for clinically significant prostate cancer. Quant Imaging Med Surg Wang W, Zheng X, Wang J, Liu N, Cai S, Xu Y. PMID: 42273125 [PubMed]
	Methodological considerations in a real-world study of first-line nivolumab plus ipilimumab for metastatic renal cell carcinoma. J Oncol Pharm Pract Das S, Dhyani A, Kumar R, Arora H. PMID: 42272406 [PubMed - as supplied by publisher]
	Integrating large language models into prostate cancer training: evidence from comparative benchmarking and a pilot randomized trial. BMC Med Educ Liu X, Chen M, Cai Y. PMID: 42271392 [PubMed - as supplied by publisher]
	A systematic review and meta-analysis of treatment-induced hypertension risks from androgen receptor pathway inhibitors in randomized controlled trials for prostate cancer. BMC Cancer Gong Q, Ge F, Chen T. PMID: 42271285 [PubMed - as supplied by publisher]
	Comparative efficacy and safety of carboplatin-based versus cisplatin-based chemotherapy in muscle-invasive and advanced bladder cancer: A systematic review and meta-analysis. Eur J Clin Pharmacol Liao J, Li X, Li G. PMID: 42271082 [PubMed - in process]
	Preoperative prediction of pathological pelvic lymph node metastasis in prostate cancer using an elastic net model integrating clinicopathologic and (68)Ga-PSMA PET/CT features: development and temporal validation. Sci Rep Chen Y, Gao L, Zheng Z, Feng P, Zhang C, Shi G, Li S, Hu J, Wang L, Wu B, Cao X. PMID: 42270733 [PubMed - as supplied by publisher]
	Comment on 'A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer'. BJU Int Urolagin D, Sowmya BA, Kavyashree MV. PMID: 42269719 [PubMed - as supplied by publisher]
	Effect of [(68)Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial. Lancet Oncol Buteau JP, Moon D, Fahey MT, Roberts MJ, Ayati N, Papa N, Murphy DG, Kasivisvanathan V, Dhillon HM, Du YT, Dundee P, Foudoulis J, Hennes D, Hutton AC, Idiare J, Jack G, Kamath S, Lee SN, Lee SF, Lee ST, Leslie S, Levy SM, Link E, Mitchell C, Morigi JJ, Nguyen A, Olphert J, Patel MI, Pattison DA, Pearce A, Perera M, Thanigasalam R, Thomson A, Yaxley J, Thompson J, Hofman MS, Emmett L, PRIMARY2 Trial Investigators. PMID: 42269655 [PubMed - as supplied by publisher]
	Cell-free DNA in prostate cancer and treatment selection. Expert Rev Anticancer Ther McKendry K, Maurice-Dror C, Chi KN. PMID: 42269177 [PubMed - as supplied by publisher]
	Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity. J Urol George A, Giesler E, Mazzarella B, Levin R, Frendl D, Warlick C, Given R, Kella N, Frye T, Mynderse L, Kasraeian A, Milbank A, Nabbout P, Grunberger I, Rastinehad A, Schwartz M, Wysock J, Rousseau M, Pliskin M, Satkunasivam R, Rich D, Shore ND, Moreno J, Belkoff L, Sidana A, Taneja SS. PMID: 42269147 [PubMed - as supplied by publisher]
	Influence of Artificial Intelligence Assistance on Gleason Grading and Prostate Cancer Detection by Uropathologists in Daily Practice: A Prospective Multicenter Study. JCO Clin Cancer Inform van Hees JE, van Diest PJ, Nguyen TQ, Lynch MG, Jonges TN, Meijer RP, Willemse PM, Suelmann BBM, van Dooijeweert C. PMID: 42269140 [PubMed - in process]
	Change in Adherence to Oral Antidiabetic Medications Before and After Prostate Cancer Diagnosis: A Group-Based Trajectory Modeling Approach. Clin Drug Investig Kenawy AS, Baffoe JO, Park C. PMID: 42268571 [PubMed - as supplied by publisher]
	Identifying PLAU as a shared pathogenic gene in type 2 diabetes and bladder urothelial carcinoma through integrated transcriptomic analysis and machine learning for diagnostic and therapeutic value. Clin Exp Med Xin S, Li G, Yang X, Su J, Li R, Qin W, Zhang Z, Wang C, Zhu Y, Feng L, Ren S, Gao Z. PMID: 42268472 [PubMed - as supplied by publisher]
	Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma. Cancer Drug Resist Zhang Y, Zhu Y, Liu Z, Li H, Zhong B, Cui X, Kong Y, Lu H. PMID: 42267194 [PubMed]
	Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges. Front Immunol Ren S, Pan F, Jin J. PMID: 42266702 [PubMed - in process]
	The international and domestic research trends of targeted therapy in bladder cancer: a bibliometric analysis of the past three decades. Front Oncol Pan Y, Sun Y, Jiao B, Zhang Y, Zhang G. PMID: 42266656 [PubMed]
	Self-Management Experience of Chinese Patients With Nonmuscle-Invasive Bladder Cancer During Intravesical Therapy: A Qualitative Study. Cancer Nurs Deng C, Soivong P, Akkadechanunt T, Sethabouppha H. PMID: 42266078 [PubMed - as supplied by publisher]
	A Nomogram for Predicting 28-Day Mortality in Critically Ill Patients With Prostate Cancer: A Retrospective Cohort Study Based on the MIMIC-IV Database. Arch Esp Urol Yao Y, Dong J, Wang Z, Su Y. PMID: 42265963 [PubMed - in process]

Articles 1 - 20 / 188482

Page 1 of 9425



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy